T cell loss weakens cancer immunity in middle-aged male mice

The immune system needs so-called naive T cells to recognise new threats, including cancer cells. Naive T cells are produced in the thymus and have not been previously activated. They function as the reserve troops of the immune system.

The study, published in Nature Aging, shows that male mice in middle age lose naive CD8+ T cells more rapidly than female mice. These cells are specifically involved in the defence against tumours. As those cells declined, the lymph node network that houses them also shrank. The result: the immune system recognised cancer antigens less effectively and responded more weakly to immunotherapy.

Thymic activity as the key link

The thymus is the organ where T cells mature. After puberty, this organ gradually shrinks, reducing the production of new naive T cells. The researchers restored thymic output in the mice, which led to more naive CD8+ T cells. That substantially improved their response to immunotherapy. The researchers also present supporting data in humans, although this evidence is limited in scope.

The sex difference is striking: in male mice, the loss of naive T cells proceeds more rapidly. Whether this applies equally strongly in humans cannot be definitively concluded from this study.

Implications for cancer therapy in older patients

Immunotherapy for cancer tends to work less well as patients age. This study offers a possible explanation for that pattern, at least in middle-aged male mice. If restoring thymic activity also improves immune responses to cancer therapy in humans, it could represent a relevant addition to existing treatments. That requires further clinical investigation.

For longevity science, this is an important signal: the immune system begins structurally losing its capacity to fight cancer already in middle age.

Read the original article